Today in wah wah wah news, Addyi, the pharmaceutical intended to enhance female desire, is turning out to be less than thrilling. The drug was approved by the FDA last year and was marketed as the first “female viagra,” but so far taking the supposed libido pill is said to result in just “half of one satisfying sexual encounter a month,” according to the New York Times. A study which looked at nearly 6,000 women found that Addyi simply was not effective, especially considering its numerous side effects.
“[Some] public health groups and some other women’s groups contended that the science did not justify its approval. The drug’s effects were modest, they said, and not worth side effects such as sleepiness, dizziness, fatigue, and nausea,” reported the Times. Not only that, but the study was not able to define what “half of one satisfying sexual encounter a month” even meant (half an orgasm? Sex was kinda-sorta okay?). Before this report, consumers were already skeptical about Addyi’s abilities, and sales of the drug have not been robust. We can only guess that this new report is probably going to take the wind out of Addyi’s sails for good, if you know what we mean.
Looking for a definitively satisfying sexual encounter? You don’t need Big Pharma for that—we’ve got all the thrills and none of the side effects right here!
Check out more about ‘female viagra’s’ disappointing data here: https://jezebel.com/addyi-the-
@NiteFlirt